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In a preceding study, we showed that in adult pink1−/− mice, a monogenic
animal model of Parkinson’s disease (PD), striatal neurons display aberrant electrical
activities that precede the onset of overt clinical manifestations. Here, we tested
the hypothesis that the maturation of dopaminergic (DA) neurons of the pink1−/−
substantia nigra compacta (SNc) follows, from early stages on, a different developmental
trajectory from age-matched wild type (wt) SNc DA neurons. We used immature
(postnatal days P2–P10) and young adult (P30–P90) midbrain slices of pink1−/−
mice expressing the green fluorescent protein in tyrosine hydroxylase (TH)-positive
neurons. We report that the developmental sequence of N-Methyl-D-aspartic acid
(NMDA) spontaneous excitatory postsynaptic currents (sEPSCs) is altered in pink1−/−
SNc DA neurons, starting from shortly after birth. They lack the transient episode
of high NMDA receptor-mediated neuronal activity characteristic of the immature
stage of wt SNc DA neurons. The maturation of the membrane resistance of
pink1−/− SNc DA neurons is also altered. Collectively, these observations suggest that
electrical manifestations occurring shortly after birth in SNc DA neurons might lead
to dysfunction in dopamine release and constitute an early pathogenic mechanism
of PD.
Keywords: pink1-deficient mouse, substantia nigra, dopaminergic neurons, development, spontaneous AMPA
EPSCs, spontaneous NMDA EPSCs, patch clamp, Parkinson’s disease
INTRODUCTION
Dopaminergic (DA) neurons of the substantia nigra compacta (SNc) degenerate progressively
during the course of Parkinson’s disease (PD; Kordower et al., 2013). Whether and when
they dysfunction during the early stages of PD before degenerating remains largely unknown.
Addressing this question requires progressive animal models of PD, like genetic models of familial
forms of PD. Particularly interesting are pink1-deficient mice, which do not express the PTEN-
induced kinase 1 (pink1), a ubiquitously expressed mitochondrial kinase consisting of 581 amino
acids that encode for a mitochondrial targeting sequence, a transmembrane domain and a Ser/Thr
kinase domain (Silvestri et al., 2005; Gandhi et al., 2006; Zhou et al., 2008; Gispert et al., 2009).
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Pink1 is a mitochondrial quality control factor with functions
in repair, fission and autophagic elimination (Deng et al.,
2008; Poole et al., 2008; Yang et al., 2008; Gehrke et al., 2015).
Pink1 induces mitophagy. Upon mitochondrial damage, pink1
is stabilized on the outer mitochondrial membrane, where it
phosphorylates ubiquitin and activates the ubiquitin ligase
parkin. This builds ubiquitin chains on mitochondrial
outer membrane proteins and leads to removal of damaged
mitochondria by autophagy (Narendra et al., 2010; Koyano
et al., 2014; Kazlauskaite and Muqit, 2015; Lazarou et al., 2015;
Ordureau et al., 2015).
Pink1-deficient mice are a model of the PARK6 variant of
PD (mutations in PINK1), the second most common cause
of autosomal recessive familial early-onset PD (Bentivoglio
et al., 2001; Valente et al., 2004; Bonifati et al., 2005; Gasser,
2009). In this model, the first conspicuous motor abnormalities
are manifest at 16 months, offering a large time window to
explore earlier subclinical abnormalities (Gispert et al., 2009).
During this window, profound dysfunction is observed in
the basal ganglia system. Though pink1−/− DA SNc neurons
are preserved during the murine lifespan, they progressively
show mitochondrial dysfunction, impaired intracellular calcium
signaling leading to functional reduction of the activation of
the small K (SK) calcium-activated channels, irregular firing
and a greater tendency to fire bursts of action potentials by
1–4 months (Gispert et al., 2009; Bishop et al., 2010). In addition,
evoked dopamine release is reduced in the striatum, and cortico-
striatal synaptic plasticity is disrupted by 3 months. Half the
striatal projection neurons (medium spiny neurons, MSNs) show
aberrant morphology and generate giant GABAergic currents by
3–6months. These constitute an electrophysiological signature of
dopamine depletion and PD, since they are reversed by chronic
levodopa administration or subthalamic nucleus (STN) lesion
used to treat PD (Kitada et al., 2007; Gautier et al., 2008; Dehorter
et al., 2009, 2012; Gispert et al., 2009; Wang et al., 2011).
These observations suggest that early sub-clinical
manifestations can occur, possibly leading to very early
deviations in developmental processes that culminate
progressively in motor disturbances. A wide range of
experiments suggest that ionic currents, like the brain patterns
they generate, follow developmental sequences playing specific
roles in the developing brain, which when deviated lead to
long-term neurological deleterious sequels (Ben-Ari, 2008).
Since α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(AMPA) and N-methyl-D-aspartic acid (NMDA) receptor
activation generates transient high-frequency activity in SNc
DA neurons, alterations of their properties during development
could produce long-term alterations in SNc DA neurons. Our
finding that the developmental sequence of NMDA currents and
membrane resistance are altered in pink1−/− SNc DA neurons
could explain dysfunction in dopamine release later in adulthood
(Schmitz et al., 2009).
MATERIALS AND METHODS
All experiments were approved by the Institut National de la
Santé et de la RechercheMédicale (INSERM) animal care and use
agreement (D-13-055-19) and the European community council
directive (2010/63/UE). Animals had access to food and water
ad libitum and were housed in our institutional animal facilities
under a 12 h light/dark cycle at 22–24◦C.
Mice
We used immature (P2–10) and young adult (P30–90) tyrosine
hydroxylase (TH)-GFP mice as control wild type (wt) mice
(Pearlstein et al., 2015) and pink1-deficient TH-GFP mice as
pink1−/− mice. To generate pink1−/− TH-GFP mice, TH-GFP
mice of the 129/Sv background were interbred with pink1−/−
mice of the same background. Pink1−/− TH-GFP mice were
subsequently identified using PCR-based genotyping. Then
pink1−/− TH-GFP mice were regularly crossed with pink1−/−
mice to generate pups. At P2–P5, TH-GFP and pink1−/− TH-
GFP pups were differentiated from wt pups via a UV lamp (see
Pearlstein et al., 2015).
For slice preparation, drugs, cell labeling and TH
immunocytochemistry, see Pearlstein et al. (2015).
Electrophysiology
All recordings were made in whole-cell voltage-clamp
configuration. Rm and Cm were measured during a
800 ms/−10 mV step from holding potential (−60 mV). Rm was
calculated using the following formula: Rm = ∆V(1/∆Islow −
1/∆Imax), where ∆V is the amplitude of the voltage step, ∆Imax
is the difference between holding current value and the peak
intensity reached by the capacitive current at the start of the
hyperpolarizing pulse, and ∆Islow is the difference in current
intensity between holding current value and that of the steady-
state current measured after the capacitive current. Cm was
calculated as: Cm = τw/Rm where τw is the weighted membrane
time constant (Marcaggi et al., 2003). We measured Ih amplitude
by subtracting the amplitude of the current at the end of the
800 ms hyperpolarizing step to −140 mV (VH = −60 mV) from
the amplitude of the current 15 ms after the first capacitative
current. We measured spontaneous AMPA/Kainate (KA)
currents in voltage-clamp mode at VH = −60 mV in the
continuous presence of Gabazine (5 µM) to block GABAA
receptors. We measured spontaneous NMDA currents in
voltage-clamp mode at VH = +40 mV in the continuous
presence of Gabazine (5 µM) and NBQX (10 µM) to block
GABAA and AMPA/KA receptors, respectively. These currents
were stored on a computer using Pclamp8 software (Molecular
Devices) and analyzed off-line with a Mini Analysis software
(Synaptosoft 6.0), to determine the inter-event intervals (IEIs),
amplitude, rise time and decay time of spontaneous currents.
The decay of spontaneous synaptic currents was well fitted by a
single-exponential function, starting at the peak of the current to
the time point when the current had decayed to 99.9% of its peak
amplitude. All detected currents were then visually inspected
to reject artifactual events. NMDA spontaneous excitatory
postsynaptic currents (sEPSCs) occurred either as single events
or in bursts. We defined a burst of NMDA sEPSCs as the
occurrence of at least three superimposed NMDA sEPSCs and a
bursty pattern as at least two bursts/cell/3 min. Miniature AMPA
or NMDA currents, recorded in the presence of Tetrodotoxin
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(TTX; 1 µM), were not studied because they had an extremely
low frequency at all ages tested.
Statistics
Results are given as mean ± standard error of the mean.
The non-parametric Mann-Whitney test (Graphpad Prism 6
software, San Diego, CA, USA) was used to compare results
from Pink1−/− to wt SNc DA neurons (at P2–3, P4–10 and
P30+). Since amplitude, IEI, rise time and decay time of sEPSCs
were not normally distributed, we also calculated the median
value of these parameters (± standard error of the mean of
medians) for each cell (data not shown). Statistical significance
was not different when comparing means or medians. We
pooled the results obtained between P4 and P10 because there
was no significant difference between the full set of results
obtained at P4–5 and at P8–10 for AMPA- and NMDA-mediated
sEPSCs (data not shown). For example, there was no significant
difference in frequency (P = 0.3; Mann-Whitney test), and
amplitude (P = 0.5; Mann-Whitney test) of AMPA sEPSCs.
Similarly, there was no significant difference in IEI, (P = 0.35;
Mann-Whitney test) and amplitude (P = 0.52; Mann-Whitney
test) of single NMDA sEPSCs. We used the χ2 or Fisher’s
exact test to compare proportions. For each test performed,
the P value was provided and the statistical significance was
set at P ≤ 0.05. In all figures: ∗P < 0.05, ∗∗P < 0.01 and
∗∗∗P < 0.001.
RESULTS
Intrinsic Membrane Properties of Pink1−/−
SNc DA Neurons did not Develop in the
Same Way as those of wt
The somato-dendritic field of pink1−/− SNc DA neurons did not
significantly change between P4–10 (n= 19) and P30+ (n= 14),
as already described for wt SNc DA neurons. The mean surface
area of somas was 385 ± 40 µm2 at P4–10 and 227 ± 18 µm2
at P30+. The mean number of dendritic trunks was 4.4 ± 0.3
at P4–10 and 4.6 ± 0.3 at P30+ (P = 0.6), the mean number of
dendritic ends was 13± 1 at P4–10 and 11± 1 at P30+ (P= 0.5),
the mean total dendritic length was 1535± 179µm at P4–10 and
1336 ± 130 at P30+ (P = 0.5) and the mean dendritic volume
was 4.5 × 106 ± 0.9 × 106 µm3 at P4–10 and 5.4 × 106 ± 1.2
× 106 at P30 (P = 0.5). The axon originated either from the
soma (n = 13/18 at P4–10; n = 3/14 at P30+) or from a primary
dendritic trunk (n= 5/18 at P4–10; n= 11/14 at P30+), as already
described for wt P4-P50 SNc DA neurons (Häusser et al., 1995;
Gentet and Williams, 2007; Blythe et al., 2009; Pearlstein et al.,
2015). Compared to age-matched somas surfaces or dendritic
trees of wt SNc DA neurons (Pearlstein et al., 2015), there was
no significant difference in any of the above parameters (data not
shown).
At immature stage (P4–10), the meanmembrane resistance of
pink1−/− SNc DA neurons (545 ± 104 M, n = 37) was similar
(P= 0.96) to that of wt (469± 54M, n= 27). However at young
adult stage (P30+), the membrane resistance of pink1−/− SNc
DA neurons was still the same (462 ± 72 M, n = 23; P = 0.8),
while that of wt had dramatically diminished (231 ± 18 M,
n = 17) and was twice lower (P = 0.003; Figure 1A). Mean Cm
of pink1−/− SNc DA neurons at P4–10 was twice that of age-
matched wt SNcDA neurons (15.0± 2.2 pF n= 37 vs. 7± 0.9 pF,
n = 27; P = 0.007) while at P30+, Cm of pink1−/− and wt were
not different (5.0 ± 1.2 pF, n = 24 vs. 5.4 ± 1.02 pF, n = 17;
P = 0.24; Figure 1B).
The H current density (Ih/Cm) was significantly smaller
(P < 0.0001) in P4–10 Pink1−/− SNc DA neurons than in wt
(−32.9 ± 8.1 pA/pF, n = 27 vs. −61.8 ± 8.1 pA/pF). However
at P30+, pink1−/− and wt SNc DA neurons had comparable
(P = 0.22) Ih current densities (−94.8 ± 30.8 pA/pF, n = 23 vs.
−91.6± 17.2 pA/pF, n= 17; Figure 1C).
AMPA Receptor-Mediated sEPSCs of
Pink1−/− SNc DA Neurons Follow the
Same Postnatal Developmental Sequence
as wt SNc DA Neurons
As wt SNc DA neurons (Pearlstein et al., 2015), neither
immature nor young adult pink1−/− SNc DA neurons generate
spontaneous KA-receptor-mediated EPSCs.
At immature stage (P4–10), AMPA receptor-mediated
sEPSCs (AMPA sEPSCs) of pink1−/− SNc DA neurons had
similar mean amplitudes and lengths of IEIs (17.2 ± 1.3 pA;
3.9 ± 0.7 s; n = 25) to those of wt (16.0 ± 1.9 pA; 4.4 ± 0.7 s;
n = 24; P = 0.1; P = 0.32;). Their mean rise (1.26 ± 0.06 ms
in pink1−/−; 1.17 ± 0.08 ms in wt) and decay (8.0 ± 0.5 ms in
pink1−/−; 9.2 ± 1.6 ms in wt) times were also similar (P = 0.23;
P = 0.36; Figures 2A,B). At young adult stage (P30+), mean
amplitudes and IEIs of P30+ AMPA sEPSCs were similar in
pink1−/− (13.1± 0.8 pA; 3.8± 0.9 s; n= 21) and wt (11.8± 1.0;
2.1 ± 0.4 s; n = 19) SNc DA neurons (P = 0.2; P = 0.5). Mean
rise (1.8 ± 0.5 ms in pink1−/−; 1.11 ± 0.09 ms in wt) and
decay (5.0 ± 0.5 ms in pink1−/−; 5.8 ± 1.0 ms in wt) times
(P = 0.9; P = 0.9) were also similar (Figures 3A,B). We have
previously shown that wt immature AMPA sEPSCs had larger
amplitudes and longer IEIs than young adult ones (Pearlstein
et al., 2015). AMPA sEPSCs of immature pink1−/− SNc DA
neurons also had a significantly larger mean amplitude than did
young adult neurons (P = 0.005; see Figure 7A). In contrast,
the mean length of IEIs of AMPA sEPSCs of pink1−/− SNc DA
neurons did not differ significantly between P4–10 and P30+
(P = 0.45; Figures 2B, 3B, see Figure 7B).
The wt Developmental Sequence of
NMDAR-Mediated Spontaneous Currents
is Abolished in Pink1−/− SNc DA Neurons
In this set of experiments, we first observed at P4–10 a drastic
change in the developmental sequence of NMDA sEPSCs in
pink1−/− compared to wt SNc DA neurons. To determine
whether this developmental sequence had shifted towards
younger ages, we recorded NMDA sEPSCs at P2–3 in both wt
and mutated mice.
At P2–3, 59% of pink1−/− (10/17) vs. 100% (13/13) of wt SNc
DA neurons generated NMDA sEPSCs. Single P2–3 pink1−/−
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FIGURE 1 | Developmental profile of membrane resistance
(A), membrane capacitance (B) and H current density (C) in pink1−/−
(red) and wild type (wt; blue) Substantia nigra compacta (SNc)
dopaminergic (DA) neurons.
NMDA sEPSCs had similar mean amplitudes (23.3 ± 4.0 pA;
n = 10; P = 0.23) but much longer mean IEIs (48.6 ± 16.0 s;
P = 0.0006) than age-matched wt DA neurons (16.6 ± 1.4 pA;
8.3 ± 1.1 s; n = 13). As they were very immature signals,
these NMDA sEPSCs had very long mean rise (pink1−/−:
12.3 ± 0.9 ms; wt: 11.0 ± 0.6 ms; P = 0.1) and decay
(pink1−/−: 224.6 ± 43.4 ms; wt: 187.1 ± 30.2 ms; P = 0.5) times
(Figures 4A,B).
At P4–10, single NMDA receptor-mediated sEPSCs (NMDA
sEPSCs) of P4–10 pink1−/− SNc DA neurons had significantly
smaller amplitudes and longer IEIs (17.1 ± 1.4 pA; 6.8 ± 1.0 s;
n = 18) than wt ones (29.3 ± 2.7 pA; 3.6 ± 0.6 s; n = 20;
P= 0.0002; P= 0.012). In contrast, their mean rise (7.0± 0.2 ms
in pink1−/−; 7.3 ± 0.2 ms in wt) and decay (81.4 ± 5.5 ms in
pink1−/−; 101.5 ± 3.8 ms in wt) times were similar (P = 0.8;
P = 0.1; Figures 5A,B).
At young adult stage (P30+), the situation was comparable.
Amplitude and IEIs of P30+ NMDA sEPSCs were significantly
smaller and longer in pink1−/− (14.8 ± 1.2 pA; 11.5 ± 1.6
s; n = 19) than in wt (20.0 ± 1.7 pA; 6.3 ± 0.9 s; n = 18;
P = 0.005; P = 0.014) DA SNc neurons. But their mean
rise (6.8 ± 0.5 ms in pink1−/−; 7.6 ± 0.4 ms in wt) and
decay (86.1 ± 7.3 ms in pink1−/−; 75.5 ± 4.5 ms in wt)
times were similar (P = 0.3; P = 0.8; Figures 6A,B). We
previously showed that wt NMDA sEPSCs had larger amplitudes
and shorter IEIs at P4–10 than at P30+ (Pearlstein et al.,
2015). The situation was strikingly different for the amplitude
of pink1−/− NMDA sEPSCs neurons, being similar in the
two age groups (P = 0.9; see Figure 7C). Only the mean
lengths of IEIs differed significantly between the two age groups
(IEI were shorter at P4–10 than at P30+; P = 0.033; see
Figure 7D).
Immature pink1−/− NMDA sEPSCs rarely occurred in bursts
(involving 3–5 events), in contrast to the age-matched wt group
(Pearlstein et al., 2015). There were far fewer (P < 0.001, χ2 test)
pink1−/− SNc DA neurons showing a bursty pattern of NMDA
sEPSCs (see ‘‘Materials and Methods’’ Section) at P2–3 (30%,
n = 3/10, 35 bursts in 3 neurons) than age-matched wt ones
(92%, n = 12/13, 86 bursts in 12 neurons). Bursts of NMDA
sEPSCs were present in only 11% (2/18) of P4–10 pink1−/−
SNc DA neurons (5 bursts in 2 neurons) compared to 60%
(12/20) in wt SNc DA neurons (146 bursts in 12 neurons;
P < 0.001, χ2 test). In young adults (P30+), the percentage of
bursting DA neurons was comparable (P = 1, Fisher’s exact
test) in pink1−/− (16%; 3/19 neurons, 26 bursts in 3 neurons)
and wt (11%; 2/18 neurons; 26 bursts in 3 neurons) SNc (see
Figure 7E).
Lack of GluN2C/D-Containing NMDARs in Immature
Pink1−/− SNc Neurons
In contrast to wt, Pink1−/− NMDA sEPSCs did not show
different pharmacological sensitivity with age (Pearlstein et al.,
2015). DQP 1105 (10 µM), a preferential antagonist of GluN2D-
containing NMDA receptors (previously termed NR2D in
rodents and corresponding to GRIN2D in humans), had no effect
on the amplitude (21.8 ± 5.1 pA before and 24.4 ± 5.0 pA
during DQP, n = 5; P = 0.06) and frequency (0.25 ± 0.07
Hz before and 0.20 ± 0.02 Hz during DQP, n = 5; P = 0.3)
of P4–10 single pink1−/− NMDA sEPSCs. DQP too had no
effect on the amplitude and frequency of P30+ single pink1−/−
NMDA sEPSCs (14.7 ± 1.3 pA before and 13.6 ± 1.4 pA
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FIGURE 2 | α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) spontaneous excitatory postsynaptic currents (sEPSCs) in immature
(P4–10) pink1−/− SNc DA neurons and comparison with age-matched wt SNc DA neurons. (A) Voltage-clamp recordings of AMPA sEPSCs from a P8
pink1−/− (red) and a P6 wt (blue) SNc DA neurons in the continuous presence of gabazine (5 µM) and APV (40 µM) at VH = −60 mV. AMPA events indicated by a
dot are enlarged and superimposed in the inset. (B) Quantification and statistical comparison of the amplitudes and inter-event intervals (IEIs) and of the rise and
decay times of P4–10 pink1−/− (n = 25) and wt (n = 24) AMPA sEPSCs, as indicated.
during DQP, n = 6, P = 0.6; 0.21 ± 0.10 Hz before and
0.31 ± 0.14 Hz during DQP, n = 6, P = 0.5; data not
shown). Since very few pink1−/− SNc neurons had a bursty
pattern at P4–10 or P30+, we did not test DQP on burst
characteristics. These results show the lack of effect of DQP
1105 (10 µM) in immature pink1−/− SNc DA neurons. This
differs radically from findings for wt P4–10 SNc DA neurons,
where DQP reduced both the frequency of single NMDA
sEPSCs and the occurrence of bursts of P4–10 NMDA sEPSCs
(Pearlstein et al., 2015). Ro 25-6981 (1 µM) abolished all single
and bursting NMDA sEPSCs in P4–10 and P30+ pink1−/−
SNc neurons (data not shown). The above results also suggest
that all spontaneously activated NMDA receptors, from P4
to P90 pink1−/− SNc DA neurons, contained the GluN2B
subunit.
DISCUSSION
The main result shown here is that pink1−/− SNc DA
neurons lack the characteristic wt developmental sequence
of NMDA sEPSCs identified between P2 and P10, which
consists of large amplitude and high frequency events associated
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FIGURE 3 | AMPA sEPSCs in young adult (P30+) pink1−/− SNc DA neurons and comparison with age-matched wt SNc DA neurons. (A) Voltage-clamp
recordings of AMPA sEPSCs from a P30 pink1−/− (red) and a P39 wt (blue) SNc DA neuron in the continuous presence of gabazine (5 µM) and APV (40 µM) at
VH = −60 mV. AMPA events indicated by a dot are enlarged and superimposed in the inset. (B) Quantification and statistical comparison of the amplitudes and IEIs
and of the rise and decay times of P30+ pink1−/− (n = 21) and wt (n = 19) AMPA sEPSCs, as indicated.
to a characteristic bursting pattern. The absence of this
high NMDA activity at immature stage drastically changes
the developmental profile of NMDA sEPSCs in pink1−/−
SNc DA neurons. This may have consequences on calcium
influxes into developing dendrites and somas. In contrast,
there is a similar developmental profile of AMPA sEPSCs,
i.e., immature AMPA sEPSCs with larger amplitudes and
longer IEIs than young adult ones, in pink1−/− and wt
(Pearlstein et al., 2015) SNc DA neurons. This abnormal skip
in the NMDA developmental sequence recorded in vitro in
coronal slices most probably concerns glutamatergic synapses
between midbrain glutamatergic neurons located in the Ventral
tegmental area (VTA) and/or in the SNc and SNc DA
neurons.
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FIGURE 4 | Single N-methyl-D-aspartic acid (NMDA) sEPSCs P2–3 pink1−/− SNc DA neurons and comparison with age-matched wt SNc DA neurons.
(A) Voltage-clamp recordings of NMDA sEPSCs from a P2 pink1−/− (orange) and a P2 wt (turquoise blue) SNc DA neuron in the continuous presence of gabazine
(5 µM) and NBQX (10 µM) at VH = +40 mV. The NMDA events indicated by a dot are enlarged and superimposed in the inset. (B) Quantification and statistical
comparison of the amplitudes and IEIs and of the rise and decay times of P2–3 pink1−/− (n = 10) and wt (n = 13) NMDA sEPSCs, as indicated.
Maturation of the morphological properties of wt SNc DA
neurons is achieved during the very early prenatal period in
mice (Ferrari et al., 2012), and rats (Tepper et al., 1994; Park
et al., 2000). We found comparable morphological maturation
for pink1−/− SNc DA neurons, with their dendritic tree already
mature at P4–10. In contrast, intrinsic membrane properties
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FIGURE 5 | Single NMDA sEPSCs in immature (P4–10) pink1−/− SNc DA neurons and comparison with age-matched wt SNc DA neurons.
(A) Voltage-clamp recordings of NMDA sEPSCs from a P8 pink1−/− (red) and a P8 wt (blue) SNc DA neuron in the continuous presence of gabazine (5 µM) and
NBQX (10 µM) at VH = +40 mV. The NMDA events indicated by a dot are enlarged and superimposed in the inset. (B) Quantification and statistical comparison of
the amplitudes and IEIs and of the rise and decay times of P4–10 pink1−/− (n = 18) and wt (n = 20) NMDA sEPSCs, as indicated.
developed differently. The membrane resistance of pink1−/−
SNc DA neurons did not diminish between P4–10 and P30+
in the manner observed for wt neurons (Pearlstein et al.,
2015), suggesting the maintenance of immature features in
pink1−/− SNc DA neurons. This paves the way for alterations
in both intrinsic and evoked activities in pink1−/− SNc DA
neurons, as high input resistance facilitates the generation of
oscillations.
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FIGURE 6 | Single NMDA sEPSCs in young adult (P30+) pink1−/− SNc DA neurons and comparison with age-matched wt SNc DA neurons.
(A) Voltage-clamp recordings of NMDA sEPSCs from a P41 pink1−/− (red) and a P39 wt (blue) SNc DA neuron in the continuous presence of gabazine (5 µM) and
NBQX (10 µM) at VH = +40 mV. The NMDA events indicated by a dot are enlarged and superimposed in the inset. (B) Quantification and statistical comparison of
the amplitudes and IEIs and of the rise and decay times of P30+ pink1−/− (n = 19) and wt (n = 18) NMDA sEPSCs, as indicated.
To date, the nature of the intrinsic current underlying
these changes has not been determined. Cationic H channels
do not appear to be involved: the amplitude of Ih at P30+
is similar. Further experiments are required to shed light
on these differences, which are clearly not the consequence
of morphological features, since dendritic arborizations and
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FIGURE 7 | Developmental profile in pink1−/− (red) and wt (blue) SNc DA neurons of the amplitude (A) and IEIs (B) of AMPA sEPSCs; of the amplitude
(C) and IEIs (D) of NMDA sEPSCs; of the percentage of neurons with bursts of NMDA sEPSCs (E).
soma surfaces were similar in wt and pink1−/− SNc DA
neurons.
The absence of large and frequent NMDA events with a
bursty pattern at immature stage (P2 to P10) was the striking
difference between pink1−/− and wt SNc DA neurons. Even
later, at young adult stage (P30–P90), synaptic NMDA activity
remained limited, with smaller and less frequent NMDA sEPSCs.
The absence of bursts of NMDA sEPSCs and the lack of effect of
DQP 1105, a preferential antagonist of NR2D-containing NMDA
receptors, confirm that the glutamatergic synapses afferent to
pink1−/− SNc DA neurons studied here in coronal slices are
different from the wt ones. In particular the presence of bursts
in control SNc DA neurons was correlated to the presence of
slowly-decaying NMDA events. This strongly suggests that the
dynamic remodeling of NMDA receptor subunit composition
described in midbrain regions (Monyer et al., 1994; Dunah et al.,
1996;Wenzel et al., 1996; Laurie et al., 1997; Liu andWong-Riley,
2010) during postnatal development, with GluN2D subunits no
longer present in young adult wt mice, is altered in pink1−/−
SNc DA neurons, at least for the glutamatergic synapses studied
here (see paragraph below). We propose that from P2 to P90, the
NMDA sEPSCs of pink1−/− SNc DA neurons that we recorded
in the present study result from the activation of diheteromeric
GluN1/GluN2B receptors (Dunah et al., 1998; Jones and Gibb,
2005; Brothwell et al., 2008; Suarez et al., 2010; Huang and Gibb,
2014), since all NMDA sEPSCs were antagonized by Ro 25-6981
but not by DQP 1105.
The most abundant afferent glutamatergic inputs to SNc
DA neurons come from the subthalamic and pedunculopontine
nuclei (Hammond et al., 1978, 1983; Kita and Kitai, 1987;
Smith and Grace, 1992; Iribe et al., 1999; Ammari et al., 2009).
However, given that in the presence of TTX, ongoing NMDA
receptor-mediated sEPSCs were absent, AMPA and NMDA
spontaneous events were generated by afferent action potential
firing, implying that somas of afferent glutamatergic inputs were
present in the slice. In coronal slices, STN or pedunculopontine
somas are absent, which makes the VTA (A10) and SNc (A9) the
most likely candidate glutamatergic neuronal sources (Kawano
et al., 2006; Yamaguchi et al., 2007, 2011, 2013; Stuber et al., 2010;
Tecuapetla et al., 2010; Zhang et al., 2015). Interestingly, several
studies linked polymorphisms of the GRIN2B gene (GluN2B in
rodents) to the increased risk of impulse control behavior in PD
patients under DA treatment (Lee et al., 2009; Zainal Abidin et al.,
2015).
Frontiers in Cellular Neuroscience | www.frontiersin.org 10 June 2016 | Volume 10 | Article 168
Pearlstein et al. sEPSCs in Developing Pink1−/− Dopaminergic Neurons
Summing up, our previous studies in pink1−/− mice
showed an excess of cortical synchronization at immature stage
(P15–20), followed by giant GABAergic currents in striatal
MSNs (3–6 month-old) that are reversed either by STN high
frequency stimulation (Carron et al., 2014), or chronic STN
lesion or levodopa treatment (Dehorter et al., 2012). These
features are therefore relevant to PD andmight provide biological
markers of the early stages of the disease, which in this
model is known to begin at 16 months (Gispert et al., 2009).
This would correspond to very early insults in human brain
development since postnatal days 4–10 in mice correspond
in humans to the last trimester of gestation and P20 to
delivery.
The underlying ‘‘neuroarcheology’’ concept (Ben-Ari, 2008)
has now been confirmed in several developmental disorders in
which genetic mutations like early environmental insults have
been shown to impact the development of brain networks. We
propose that the pink1 mutation deviates the developmental
sequence of NMDA currents at a very early stage, leading to
altered formation of functional neuronal ensembles that could
later culminate in clinical manifestations. Preclinical nigrostriatal
dysfunction has been previously identified in cotwins with
idiopathic PD and in asymptomatic carriers of a single mutant
PARK6 allele. Some of these subjects developed parkinsonian
signs a few years later (Piccini et al., 1997, 1999; Khan et al.,
2002). Presynaptic DA dysfunction may be a central pathogenic
precursor of PD, before leading to frank loss of nigral DA
neurons (Shen, 2010).
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